Study shows that the use of nonsteroidal anti-inflammatory drugs that inhibit PTGS1 and PTGS2 increases the risk of HF as they can reduce prostaglandin E generation that can protect the heart [43]. This evidence concerns the gene PTGS2 and hydrops fetalis.